Condition
Embryonal Tumor clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Embryonal Tumor clinical trials that are recruiting, at sites in 21 countries (most in Italy (3), United States (2), France (2)). By phase: Phase 1 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 21Countries
Newest Embryonal Tumor clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| International registry for rare embryonal tumors of the central nervous system | — | Yerevan and 10 other locations | Recruiting | Feb 3, 2023 |
| CAR T-cell therapy for pediatric brain tumors | Phase 1 | Roma, Italy | Recruiting | Mar 28, 2022 |
| Using ultrasound to open the blood-brain barrier for treating brain tumors in children | Phase 1 | Paris and 2 other locations | Recruiting | Mar 24, 2022 |
| Lutathera treatment for recurrent high-grade brain tumors | Phase 1/2 | Aurora, Colorado and 3 other locations | Recruiting | Mar 14, 2022 |
| Observational assessment of treatment outcomes for patients with primary brain tumors | — | Innsbruck and 41 other locations | Recruiting | Feb 28, 2022 |
| C7R-GD2 CAR T cells for brain tumors expressing GD2 | Phase 1 | Houston, Texas | Recruiting | Sep 23, 2019 |
All recruiting trials (6)
-
International registry for rare embryonal tumors of the central nervous system
This study is creating a database to help doctors learn more about rare brain tumors in kids and young adults, so they can improve diagnosis and treatment, especially in places where information is limited.
-
CAR T-cell therapy for pediatric brain tumors
This study is testing a new CAR T-cell therapy for kids and young adults with tough brain tumors to see if it can safely help them when other treatments have failed.
-
Using ultrasound to open the blood-brain barrier for treating brain tumors in children
This study is testing if a special ultrasound device can safely help deliver chemotherapy directly to brain tumors in children to improve their treatment.
-
Lutathera treatment for recurrent high-grade brain tumors
This study is testing if Lutathera can safely help children and young adults with recurring high-grade brain tumors that show certain markers on scans.
-
Observational assessment of treatment outcomes for patients with primary brain tumors
This study looks at how well treatments work for people with rare primary brain tumors using new classification guidelines to see if they help doctors group patients better.
-
C7R-GD2 CAR T cells for brain tumors expressing GD2
This study is testing a new treatment using specially modified immune cells to see if they can help people with certain types of brain tumors that have a specific protein called GD2.
Related topics
Quick answers
How many Embryonal Tumor clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 21 countries. The most sites are in Italy (3 trials), United States (2 trials), France (2 trials), Austria (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.